![James W. Korfhage](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James W. Korfhage
Founder at Oregon Life Sciences LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
James Hicks | M | 77 |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 years |
Jeff King | M | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 years |
Brock Metcalf | M | - |
Oregon Life Sciences LLC
![]() Oregon Life Sciences LLC Investment ManagersFinance Oregon Life Sciences LLC (Oregon Life Sciences) is a venture capital firm founded in 1994 by James Korfhage and John Metcalf. The firm is headquartered in Eugene, Oregon.
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
Renee Shirley | F | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 years |
Gilbert N. Miller | M | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
Llew Keltner | M | 74 |
Oregon Life Sciences LLC
![]() Oregon Life Sciences LLC Investment ManagersFinance Oregon Life Sciences LLC (Oregon Life Sciences) is a venture capital firm founded in 1994 by James Korfhage and John Metcalf. The firm is headquartered in Eugene, Oregon. | - |
Rob Wiltbank | M | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
William Newman | M | - |
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
C. Jespersen | M | 78 |
University of Oregon
| 5 years |
Eric David Lawson | M | 79 |
University of Oregon
| 5 years |
Timothy Boyle | M | 73 |
University of Oregon
| 4 years |
Hartmut Baitis | M | 74 |
University of Oregon
| 4 years |
Ronald Horne | M | 79 |
University of Oregon
| 4 years |
Gordon T. Frost | M | - |
University of Oregon
| 4 years |
Jan Sieberts | M | - |
University of Oregon
| 4 years |
David Lippoff | M | - |
University of Oregon
| 4 years |
Tony Keller | M | - |
University of Oregon
| 1 years |
Thomas Wikstrom | M | 76 |
University of Oregon
| 4 years |
Richard L. Fletcher | M | 84 |
University of Oregon
| - |
Carlton Cadwell | M | 79 |
University of Oregon
| 4 years |
Jim Jones | M | 82 |
University of Oregon
| - |
Bill McCorriston | M | - |
University of Oregon
| 4 years |
Choung Kim | M | - |
University of Oregon
| 3 years |
Mary Cameron | F | - |
University of Oregon
| 4 years |
Jim Jones | M | - |
University of Oregon
| 3 years |
Dennis Ciocca | M | - |
University of Oregon
| 2 years |
Dan W. Hollingshead | M | - |
University of Oregon
| 4 years |
Omar Ziad Jaafar Al-Askari | M | - |
University of Oregon
| 4 years |
John T. Lemley | M | - |
University of Oregon
| 2 years |
René Olivieri | M | - |
University of Oregon
| 4 years |
Celia H. Currin | F | 76 |
University of Oregon
| 4 years |
Michael B. Wilkes | M | - |
University of Oregon
| 4 years |
Kenneth S. Beat | M | - |
University of Oregon
| 4 years |
Richard D. Fulmer | M | 78 |
University of Oregon
| 4 years |
Greg Houser | M | 76 |
University of Oregon
| 4 years |
Charles Craig Seven | M | 80 |
University of Oregon
| 4 years |
Peter Johnson | M | - |
University of Oregon
| 4 years |
James E. Crabbe | M | 78 |
University of Oregon
| 4 years |
Mary Modesta Bersot | F | - |
University of Oregon
| 4 years |
Richard E. Hanson | M | 80 |
University of Oregon
| 4 years |
Dana Siebert | M | - |
Oregon Life Sciences LLC
![]() Oregon Life Sciences LLC Investment ManagersFinance Oregon Life Sciences LLC (Oregon Life Sciences) is a venture capital firm founded in 1994 by James Korfhage and John Metcalf. The firm is headquartered in Eugene, Oregon. | - |
David A. G. Bending | M | 70 |
University of Oregon
| 4 years |
Dan McPhun | M | - |
University of Oregon
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 43 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James W. Korfhage
- Personal Network